Ophthalmic diagnostic imaging markets projected to grow through 2035

The global markets for corneal topographers and retinal imaging devices are poised for significant expansion driven by the increasing demand for advanced ophthalmic diagnostics.

The corneal topographer market is expected to grow from a 2025 valuation of $810 million to $1.36 billion by 2035, representing a compound annual growth rate (CAGR) of 5.35%. This growth is fueled by rising refractive and cataract surgeries, increased awareness of corneal diseases, and the need for customized contact lenses. Technological integration, such as combining Scheimpflug imaging with Optical Coherence Tomography (OCT), is enhancing clinical workflows.

Simultaneously, the retinal imaging devices market is projected to expand from $4.2 billion in 2025 to $8.66 billion by 2035, with a CAGR of 7.50%. Key drivers include the management of diabetic retinopathy, age-related macular degeneration, and glaucoma. OCT systems are expected to hold a 38.60% market share in 2025, while OCT angiography (OCTA) is anticipated to be the fastest-growing device type with a 9.85% CAGR.

In the United States, the corneal topographer market is forecasted to reach $403.62 million by 2035, while the retinal imaging market is expected to reach $2.68 billion in the same period.